ScholarIQanswers from OpenAlex & ORCID
David G. Kiely
ResearcherPublications, citations & collaboration network
David G. Kiely is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David G. Kiely have?
ScholarIQindexed works
David G. Kiely has 494 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David G. Kiely have?
ScholarIQcitation count
David G. Kiely has 25,263 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David G. Kiely?
ScholarIQh-index
David G. Kiely has an h-index of 76 in OpenAlex.
What is the i10-index of David G. Kiely?
ScholarIQi10-index
David G. Kiely has an i10-index of 202 in OpenAlex.
What is the ORCID of David G. Kiely?
ScholarIQorcid
The ORCID for David G. Kiely is on the source record.
What is the OpenAlex record for David G. Kiely?
ScholarIQopenalex
The OpenAlex for David G. Kiely is on the source record.
What are the most-cited papers on David G. Kiely?
ScholarIQmost cited works
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Marc Humbert, Gábor Kovács, Marius M. Hoeper, Roberto Badagliacca, Rolf M F Berger, Margarita Brida, Jørn Carlsen, Andrew J.S. Coats, Pilar Escribano Subías, Pisana Ferrari, Diogenes S. Ferreira, Hossein Ardeschir Ghofrani, George Giannakoulas, David G. Kiely, Eckhard Mayer, Gergely Mészáros, Blin Nagavci, Karen M. Olsson, Joanna Pepke‐Żaba, Jennifer K Quint, Göran Rådegran, Gérald Simonneau, Olivier Sitbon, Thomy Tonia, Mark Toshner, Jean Luc Vachiéry, Anton Vonk Noordegraaf, Marion Delcroix, Stephan Rosenkranz, ESC/ERS Scientific Document Group, Markus Schwerzmann, Anh Tuan Dinh‐Xuan, Andy Bush, Magdy Abdelhamid, Victor Aboyans, Eloisa Arbustini, Riccardo Asteggiano, Joan Albert Barberà, Maurice Beghetti, Jelena Čelutkienė, Maja Čikeš, Robin Condliffe, Frances S. de Man, Volkmar Falk, Laurent Fauchier, Seán Gaine, Nazzareno Galiè, Wendy Gin‐Sing, John Granton, Ekkehard Grünig, Paul M. Hassoun, Merel E. Hellemons, Tiny Jaarsma, Barbro Kjellström, Frederikus A. Klok, А. О. Конради, Konstantinos C. Koskinas, Dipak Kotecha, Iréne Lang, Basil S. Lewis, Aleš Linhart, Gregory Y H Lip, Maja Lisa Løchen, Alexander G. Mathioudakis, Richard Mindham, Shahin Moledina, Robert Naeije, Jens Cosedis Nielsen, Horst Olschewski, Isabelle Opitz, Steffen E. Petersen, Eva Prescott, Amina Rakisheva, Abílio Reis, Arsen Ristić, Nicolás Roche, Rita Rodrigues, Christine Selton‐Suty, Rogério Souza, Andrew J. Swift, Rhian M. Touyz, Silvia Ulrich, Martin R. Wilkins, Stephen J. Wort
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Marc Humbert, Gábor Kovács, Marius M. Hoeper, Roberto Badagliacca, Rolf M.F. Berger, Margarita Brida, Jørn Carlsen, Andrew J.S. Coats, Pilar Escribano Subías, Pisana Ferrari, Diogenes S. Ferreira, Hossein Ardeschir Ghofrani, George Giannakoulas, David G. Kiely, Eckhard Mayer, Gergely Mészáros, Blin Nagavci, Karen M. Olsson, Joanna Pepke‐Żaba, Jennifer K Quint, Göran Rådegran, Gérald Simonneau, Olivier Sitbon, Thomy Tonia, Mark Toshner, Jean-Luc Vachiéry, Anton Vonk Noordegraaf, Marion Delcroix, Stephan Rosenkranz, the ESC/ERS Scientific Document Group
Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era
Robin Condliffe, David G. Kiely, Andrew J. Peacock, Paul A. Corris, J. Simon R. Gibbs, Florenc Vrapi, Clare Das, Charlie Elliot, Martin Johnson, Julia DeSoyza, Chantal Torpy, Kimberley Goldsmith, Denise Hodgkins, Rodney Hughes, Joanna Pepke‐Żaba, Gerry Coghlan
Improved Outcomes in Medically and Surgically Treated Chronic Thromboembolic Pulmonary Hypertension
Robin Condliffe, David G. Kiely, J. Simon R. Gibbs, Paul A. Corris, Andrew J. Peacock, David P. Jenkins, Denise Hodgkins, Kimberley Goldsmith, Rodney Hughes, Karen Sheares, Steven Tsui, Iain Armstrong, Chantal Torpy, Rachel Crackett, C Carlin, Clare Das, Gerry Coghlan, Joanna Pepke‐Żaba
Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C2 Study)
Victor F. Tapson, Zhi‐Cheng Jing, Kai‐Feng Xu, Lei Pan, Jeremy Feldman, David G. Kiely, Eugene Kotlyar, C. Shane McSwain, Kevin Laliberte, Carl Arneson, Lewis J. Rubin